Simple blood test could replace risky needle for down syndrome detection
NCT ID NCT01118507
First seen Jan 21, 2026 · Last updated Jun 17, 2026 · Updated 19 times
Summary
This study tested a new blood test that looks at fetal DNA in the mother's blood to detect Down syndrome (trisomy 21) as early as 11 weeks into pregnancy. The goal was to see if this noninvasive test could accurately tell which babies have Down syndrome, potentially replacing riskier procedures like amniocentesis. The study involved 976 pregnant women at high risk for Down syndrome.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRISOMY 21 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chi Poissy St Germain
Poissy, 78300, France
-
Necker Enfants Malades
Paris, 75015, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.